WO1998020904A3 - Flüssigkeitsgefüllte mikropartikel mit neuem wirkungsprinzip und deren verwendung als diagnostika und therapeutika - Google Patents

Flüssigkeitsgefüllte mikropartikel mit neuem wirkungsprinzip und deren verwendung als diagnostika und therapeutika Download PDF

Info

Publication number
WO1998020904A3
WO1998020904A3 PCT/EP1997/006256 EP9706256W WO9820904A3 WO 1998020904 A3 WO1998020904 A3 WO 1998020904A3 EP 9706256 W EP9706256 W EP 9706256W WO 9820904 A3 WO9820904 A3 WO 9820904A3
Authority
WO
WIPO (PCT)
Prior art keywords
diagnostic
new principle
therapeutic agents
acting according
liquid acting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP1997/006256
Other languages
English (en)
French (fr)
Other versions
WO1998020904A2 (de
Inventor
Frank Lueders
Jana Hannig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of WO1998020904A2 publication Critical patent/WO1998020904A2/de
Publication of WO1998020904A3 publication Critical patent/WO1998020904A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasonic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasonic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/225—Microparticles, microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Die Erfindung betrifft flüssigkeitsgefüllte Mikropartikel, die ihre Wirkung nach einem neuen Prinzip entwickeln, Verfahren zu deren Herstellung und die Verwendung als Therapeutika und/oder Diagnostika, wobei die Freisetzung von verkapseltem Arzneistoff und/oder Ultraschallkontrast erzeugenden Gasblasen aus den erfindungsgemäßen Mikropartikeln durch Anwendung von diagnostischem Ultraschall erfolgt.
PCT/EP1997/006256 1996-11-14 1997-11-04 Flüssigkeitsgefüllte mikropartikel mit neuem wirkungsprinzip und deren verwendung als diagnostika und therapeutika Ceased WO1998020904A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19648663.7 1996-11-14
DE1996148663 DE19648663A1 (de) 1996-11-14 1996-11-14 Flüssigkeitsgefüllte Mikropartikel mit neuem Wirkungsprinzip und deren Verwendung als Diagnostika und Therapeutika

Publications (2)

Publication Number Publication Date
WO1998020904A2 WO1998020904A2 (de) 1998-05-22
WO1998020904A3 true WO1998020904A3 (de) 1998-10-01

Family

ID=7812646

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1997/006256 Ceased WO1998020904A2 (de) 1996-11-14 1997-11-04 Flüssigkeitsgefüllte mikropartikel mit neuem wirkungsprinzip und deren verwendung als diagnostika und therapeutika

Country Status (2)

Country Link
DE (1) DE19648663A1 (de)
WO (1) WO1998020904A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248733B1 (en) 1998-01-09 2001-06-19 3M Innovative Properties Company Method for limiting the growth of microorganisms using metal-containing compounds
DE19925311B4 (de) 1999-05-27 2004-06-09 Schering Ag Mehrstufen-Verfahren zur Herstellung von gasgefüllten Mikrokapseln
US6432396B1 (en) 2000-07-06 2002-08-13 3M Innovative Properties Company Limiting the presence of microorganisms using polymer-bound metal-containing compositions
DE10147080B4 (de) * 2001-09-25 2006-05-04 Michael Schilp Verfahren zum Flüssigkeitsauftrag mittels diskret verpackter Einzelvolumina und deren Anwendung
DE102010039339A1 (de) 2010-08-16 2012-08-09 Steffen Möglich Klebesystem

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0441468A2 (de) * 1990-02-09 1991-08-14 Schering Aktiengesellschaft Aus Polyaldehyden aufgebaute gasenthaltende Mikropartikel als Kontrastmittel
WO1994028874A1 (en) * 1993-06-11 1994-12-22 Unger Evan C Novel therapeutic delivery systems
WO1995007072A2 (de) * 1993-09-09 1995-03-16 Schering Aktiengesellschaft Wirkstoffe und gas enthaltende mikropartikel
WO1995015118A1 (en) * 1993-11-30 1995-06-08 Imarx Pharmaceutical Corp. Gas microspheres for topical and subcutaneous application
WO1995022963A1 (en) * 1994-02-28 1995-08-31 Medinova Medical Consulting Gmbh Drug targeting system, method for preparing same and its use
WO1997022409A1 (en) * 1995-12-21 1997-06-26 Drexel University Hollow polymer microcapsules and method of producing

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0441468A2 (de) * 1990-02-09 1991-08-14 Schering Aktiengesellschaft Aus Polyaldehyden aufgebaute gasenthaltende Mikropartikel als Kontrastmittel
WO1994028874A1 (en) * 1993-06-11 1994-12-22 Unger Evan C Novel therapeutic delivery systems
WO1995007072A2 (de) * 1993-09-09 1995-03-16 Schering Aktiengesellschaft Wirkstoffe und gas enthaltende mikropartikel
WO1995015118A1 (en) * 1993-11-30 1995-06-08 Imarx Pharmaceutical Corp. Gas microspheres for topical and subcutaneous application
WO1995022963A1 (en) * 1994-02-28 1995-08-31 Medinova Medical Consulting Gmbh Drug targeting system, method for preparing same and its use
WO1997022409A1 (en) * 1995-12-21 1997-06-26 Drexel University Hollow polymer microcapsules and method of producing

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
PORTER T R ET AL: "INTERACTION OF DIAGNOSTIC ULTRASOUND WITH SYNTHETIC OLIGONUCLEOTIDE-LABELED PERFLUOROCARBON-EXPOSED SONICATED DEXTROSE ALBUMIN MICROBUBBLES", JOURNAL OF ULTRASOUND IN MEDICINE, vol. 15, no. 8, August 1996 (1996-08-01), pages 577 - 584, XP002054859 *
SCHROEDER-TEFFT J A ET AL: "JOURNAL OF CONTROLLED RELEASE", 15 December 1997, JOURNAL OF CONTROLLED RELEASE, VOL. 49, NR. 2-3, PAGE(S) 302-303, XP002066669 *
SOMMERFELD P. ET AL: "Long-term stability of PBCA nanoparticle suspensions suggests clinical usefulness", INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 155/2 (201-207), NETHERLANDS, XP002066668 *

Also Published As

Publication number Publication date
WO1998020904A2 (de) 1998-05-22
DE19648663A1 (de) 1998-05-28

Similar Documents

Publication Publication Date Title
IE890343L (en) Ultrasonic contrast agents, process for their preparation and their use as diagnostic and therapeutic agents
CA2349711A1 (en) A method of producing drug particles
ZA965752B (en) Triphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agents.
ZA964624B (en) Process for the preparation of microcapsule compositions.
CA2427841A1 (en) System and method for attaching upper and lower outer cases in an implantable drug pump
WO1994029351A3 (en) Antibodies
HUT54499A (en) Process for producing pharmaceutical compositions comprising 11,15-diacylprostaglandins, reducing pressure inside the eyes
WO2003050202A8 (en) A method of forming a composite
ID26207A (id) ESTRATRIENA TERSUBSTITUSI 11β-HALOGEN-7 αTERSUBSTITUTASI, PROSES UNTUK MEMPRODUKSI SEDIAAN FARMASI YANG MENGANDUNG ESTRATRIENA 11β-HALOGEN-7 αINI DAN JUGA PENGGUNAANNYA UNTUK PRODUKSI ZAT-ZAT FARMASI
ZA200202521B (en) 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preprations containing said compounds.
WO2000067847A3 (de) Verwendung von dopamin-d3-rezeptorliganden zur herstellung von arzneimittel für die behandlung von nierenfunktionsstörungen
DE59800935D1 (en) Immuntolerante prothrombinkomplex-präparation
WO1999056126A3 (de) Immunadsorptionsmatrix, verfahren zu ihrer herstellung und ihre verwendung
HU9601358D0 (en) Fluoro-phenyl-substituted alkenyl-carboxylic-guanidines, process for producing them, their use as medicines or diagnostica, and pharmaceutical compositions containing them
BG105197A (en) Polymorph form of a medicament
PL371784A1 (en) Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same
ID16989A (id) 2-naftoilguanidin tersubstitusi, proses untuk pembuatannya, pemakaiannya sebagai obat atau diagnostik, dan obat yang mengandungnya
HUP9601321A2 (en) Substituted (benzyloxy)-carbonyl-guanidine derivatives, process for producing them, pharmaceutical compositions containing them their use as pharmaceutical compositions or diagnostica, and the use of the said compds.
HUP9602640A3 (en) Substituted benzoyl-guanidine derivatives, process for producing them, pharmaceutical compositions containing them and the use of the compds.
MY113431A (en) Substituted benzenesulfonylureas and -thioureas, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
WO1998020856A3 (de) Wirkstoffhaltige Mikropartikel, diese enthaltende Mittel, deren Verwendung zur ultraschallgesteuerten Freisetzung von Wirkstoffen sowie Verfahren zu deren Herstellung
HUP0104002A3 (en) Alpha2-antagonists tricyclic delta3-piperidines, process for their producing the pharmaceutical compositions containing them and their use as medicament
ID17565A (id) Indanilidinasetilguanidin tersubstitusi, proses pembuatannya, penggunaannya sebagai obat-obatan atau diagnostik dan obat-obatan yang mengandungnya
WO2004094641A3 (en) A novel method of modulating bone-realted activity
WO1998048844A3 (de) Ionenpaare, verfahren zu ihrer herstellung und ihre verwendung als kontrastmittel

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application